Tag: Mary Glindon

The below Parliamentary question was asked by Mary Glindon on 2016-09-02.

To ask the Secretary of State for Defence, what functions undertaken by Defence Business Services are being considered for inclusion in the Corporate Services Integration and Innovation Provider contract.

Mark Lancaster

The Ministry of Defence is currently examining options for the future of Defence Business Services (DBS) as part of the Future DBS Programme. No final decisions have been taken on whether any elements of DBS current operations will be outsourced. The scope of any potential Corporate Services Integration and Innovation Provider (CSIIP) contract will be confirmed in the event that a decision to outsource is taken.

The below Parliamentary question was asked by Mary Glindon on 2015-12-10.

To ask the Secretary of State for Justice, how many prison officers have been granted retirement on the grounds of ill health in each of the last 10 years.

Mr Shailesh Vara

Prison Officers who have been granted retirement on the grounds of ill health by financial year from 2005/06 to 2015/16

All figures are rounded to the nearest 10, with numbers ending in5 rounded to the nearest multiple of 20 to prevent systematic bias. As with all HR databases, extracts are taken at a fixed point in time, to ensure consistency of reporting.

The below Parliamentary question was asked by Mary Glindon on 2016-04-27.

To ask the Secretary of State for Health, whether his Department is taking steps to encourage clinical commissioning groups to develop a commissioning policy for requests for cough assist machines for patients with muscle-wasting conditions.

Ben Gummer

The provision of cough assist machines is the responsibility of clinical commissioning groups (CCGs). Clinically led CCGs have independence and autonomy to make commissioning decisions for local populations, taking into account the available evidence and individual circumstances, as appropriate.

The evidence base to demonstrate the clinical and cost-effectiveness of the use of cough assist machines in muscle-wasting conditions is not well established. In order to improve the evidence base, the National Institute for Health Research, which is funded through the Department, is seeking to commission research on the clinical and cost-effectiveness of mechanical cough assist devices compared to other methods of sputum clearance. The deadline for outline proposals was 21 January 2016 with full proposals expected for consideration in July.

NHS England has been working with Muscular Dystrophy UK through the Bridging the Gap project to address areas of concern raised by patients and their representatives, one of which is the provision of cough assist machines. The establishment of Bridging the Gap was supported with just under £600,000 awarded by the Department through its Innovation, Excellence and Strategic Development Fund. Through this work, a number of CCGs have now developed commissioning policies which set out the circumstances in which to consider these devices based on one developed by Walsall CCG, which has been shared nationally as an example of good practice by Muscular Dystrophy UK.

On 26 April 2016, my hon. Friend the Parliamentary Under-Secretary of State, met with Muscular Dystrophy UK and a number of patient representatives specifically to hear their concerns about the provision of cough assist machines.

The below Parliamentary question was asked by Mary Glindon on 2016-09-06.

To ask the Secretary of State for Health, which of the vanguard sites for the new care models programme under the NHS England Five Year Forward View have (a) considered Hepatitis C as part of their programme and (b) engaged with operational delivery networks for Hepatitis C.

David Mowat

The new care models programme and vanguards are focusing on developing new ways of working to improve the care provided to patients and local people. Vanguards consider a range of conditions relevant to their local populations as they develop and implement their plans.

No vanguard specifically mentions hepatitis C in their plans for their new care model. However, the improvements made in many vanguards will be relevant to people with chronic conditions, including hepatitis C. In particular, the multispecialty community provider and integrated primary and acute care system vanguards are increasing the focus on prevention, long term conditions, providing more care in the community, preventing complications and admissions, and using the right technology to help patients manage their conditions.

Furthermore, the Hepatitis C Coalition has launched a national partnership working with the Department, NHS England and other partners, to provide co-ordinated action to tackle ‘upstream’ issues in prevention, awareness, testing and referrals for hepatitis C.

The below Parliamentary question was asked by Mary Glindon on 2015-12-10.

To ask the Secretary of State for Justice, how many prison officer grade staff were employed by NOMS on 31 March in each year since 2010; and how many such people were employed on the latest day for which statistics are available.

Andrew Selous

Information on the number of Band 3 to 5 prison officers in post, and on the number who joined and left the public sector Prison Service, is published in the National Offender Management Service Workforce Statistics Bulletin. The 30 September edition of the bulletin can be found at the link below.

https://www.gov.uk/government/statistics/national-offender-management-service-workforce-statistics-september-2015

“

The below Parliamentary question was asked by Mary Glindon on 2016-04-27.

To ask the Secretary of State for Health, what discussions his Department has held with patients affected by muscle-wasting conditions on the benefits of cough assist machines.

Ben Gummer

The provision of cough assist machines is the responsibility of clinical commissioning groups (CCGs). Clinically led CCGs have independence and autonomy to make commissioning decisions for local populations, taking into account the available evidence and individual circumstances, as appropriate.

The evidence base to demonstrate the clinical and cost-effectiveness of the use of cough assist machines in muscle-wasting conditions is not well established. In order to improve the evidence base, the National Institute for Health Research, which is funded through the Department, is seeking to commission research on the clinical and cost-effectiveness of mechanical cough assist devices compared to other methods of sputum clearance. The deadline for outline proposals was 21 January 2016 with full proposals expected for consideration in July.

NHS England has been working with Muscular Dystrophy UK through the Bridging the Gap project to address areas of concern raised by patients and their representatives, one of which is the provision of cough assist machines. The establishment of Bridging the Gap was supported with just under £600,000 awarded by the Department through its Innovation, Excellence and Strategic Development Fund. Through this work, a number of CCGs have now developed commissioning policies which set out the circumstances in which to consider these devices based on one developed by Walsall CCG, which has been shared nationally as an example of good practice by Muscular Dystrophy UK.

On 26 April 2016, my hon. Friend the Parliamentary Under-Secretary of State, met with Muscular Dystrophy UK and a number of patient representatives specifically to hear their concerns about the provision of cough assist machines.

The below Parliamentary question was asked by Mary Glindon on 2016-09-13.

To ask the Secretary of State for Health, what response his Department plans to make to the reports published on 9 September by (a) the Office for National Statistics and (b) Public Health England on drug-related deaths; and if he will make a statement.

Nicola Blackwood

The Government is concerned by the increase in the number of drug-related deaths registered since 2013, particularly among ageing heroin users.

Effective drug treatment helps prevent drug-related deaths. The Government provides local authorities with funding to provide drug treatment through the Public Health Grant, and the Public Health Outcomes Framework includes an indicator measuring drug-related deaths. Last year the Government amended the Medicines Regulations to enable more people to have access to naloxone which reverses the effects of heroin overdoses. Many ageing drug users also have health problems that can and should be treated by the National Health Service.

Public Health England (PHE) and the Local Government Association convened an expert group to investigate the causes of the rise in drug-related deaths and how to prevent future premature deaths. The inquiry report was published on 9 September and a copy is attached. PHE will develop a further programme of work to prevent drug-related deaths in response to the inquiry report’s recommendations.

The Advisory Council on the Misuse of Drugs has set up a working group to investigate and better understand drug-related drugs at the United Kingdom level, and we will respond in due course to any recommendations.

The below Parliamentary question was asked by Mary Glindon on 2015-12-10.

To ask the Secretary of State for Justice, how many prison officer grade staff have (a) joined and (b) left the prison service in each of the last six years.

Andrew Selous

Information on the number of Band 3 to 5 prison officers in post, and on the number who joined and left the public sector Prison Service, is published in the National Offender Management Service Workforce Statistics Bulletin. The 30 September edition of the bulletin can be found at the link below.

https://www.gov.uk/government/statistics/national-offender-management-service-workforce-statistics-september-2015

“

The below Parliamentary question was asked by Mary Glindon on 2016-05-18.

To ask the Secretary of State for Wales, what recent discussions he has had with the Secretary of State for Energy and Climate Change on the Swansea Bay tidal lagoon project.

Guto Bebb

My office remains in close contact with the Department of Energy and Climate Change on the potential development of a tidal lagoon in Swansea Bay.

We have announced an independent review into tidal power which will be led by industry expert Charles Hendry, who is well regarded across the energy industry and on both sides of the House.

The below Parliamentary question was asked by Mary Glindon on 2016-10-13.

To ask the Secretary of State for Defence, when he plans to announce the contract award date for the Defence Business Services corporate services integration and innovation provider contract; and if he will make a statement.

Mark Lancaster

The Ministry of Defence is currently examining options for the future of Defence Business Services (DBS) as part of the Future DBS Programme. No final decisions have been taken on whether any elements of DBS’ current operations will be outsourced. Timescales will be confirmed in the event of a decision to outsource.